Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 2 Interventional

Safety and Antiviral Study of ACH-126, 443 (Beta-L-Fd4C) in the Treatment of Adults With HIV Infection and Modestly Detectable Viral Load.

ClinicalTrials.gov ID: NCT00040157

Public ClinicalTrials.gov record NCT00040157. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 8, 2026, 2:48 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2 Trial of 4 Weeks of ACH-126,443 in Comparison With Continued Lamivudine in Stable Triple Antiretroviral Combination Therapy in HIV-Infected Subjects With Modestly Detectable Viral Load

Study identification

NCT ID
NCT00040157
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Lead sponsor
Alexion Pharmaceuticals, Inc.
Industry
Enrollment
60 participants

Conditions and interventions

Conditions

Interventions

  • ACH126-443 (Beta-L-Fd4C) Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Not listed
Primary completion
Not listed
Completion
Apr 30, 2003
Last update posted
Dec 29, 2015

Ends 2003

United States locations

U.S. sites
13
U.S. states
9
U.S. cities
12
Facility City State ZIP Site status
Body Positive, Inc. Phoenix Arizona 85006
Not listed Los Angeles California
Pacific Horizon Medical Group, Inc. San Francisco California 94115
Community Health Care Center One, Inc. Fort Lauderdale Florida 33306
South Shore Hospital Miami Beach Florida 33160
AIDS Research Consortium Atlanta Georgia 30308
Not listed Chicago Illinois
St. Lukes Roosevelt Hospital New York New York 10019
Stony Brook University Infectious Disease, Dept. of Medicine Stony Brook New York 11794-8153
Not listed Houston Texas 77098
Not listed Houston Texas
Hampton Road Medical Specialists Hampton Virginia 23666
Swedish Medical Center Seattle Washington 98122

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00040157, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 29, 2015 · Synced May 8, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00040157 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →